NCT00991094 Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
| NCT ID | NCT00991094 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Breast Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2005-05-27 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2005-05-27 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.
Eligibility Criteria
Inclusion Criteria: * All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol * Patients must sign a study-specific consent form prior to study entry Exclusion Criteria: * Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site
Contact & Investigator
Steven J Frank
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT00991094 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00991094 currently recruiting?
Yes, NCT00991094 is actively recruiting participants. Contact the research team at sjfrank@mdanderson.org for enrollment information.
Where is the NCT00991094 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT00991094 clinical trial?
NCT00991094 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Steven J Frank at M.D. Anderson Cancer Center. The trial plans to enroll 5,000 participants.